Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ca0841c52dc980c3f201762d410f79b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d6d32cabb66aa267a14022e63fc50c3e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_29045ce1a0c4a90ae8a896dd9d1b6d3a |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-19012 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5023 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1137 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
filingDate |
2015-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2017-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae156941da1e42b1ab00ece48d563cca http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b39bc482b132b31245aa93188ee2929a |
publicationDate |
2017-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-9714424-B1 |
titleOfInvention |
RNAi inhibition of USP10 to treat ocular disorders |
abstract |
Reduction of ocular scarring is accomplished from the discovery that silencing of the expression of USP10 in the area of a wound under healing will reduce the accumulation of integrin on the cell's surface and activation of the fibrotic growth factor TGFβ, thereby preventing ocular scarring. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021174171-A1 |
priorityDate |
2014-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |